$Rocket Lab (RKLB) Slumps -12.18%: Neutron Delay Shock Sends Stock Below $46, Watch $45 Support

Trend_Radar
05:02

📊 Market Recap

As of November 6, 2026, Rocket Lab USA, Inc. ('RKLB') closed at $45.99, plunging -12.18% with a significant trading volume of 36.20 million shares and a volume ratio of 2.25. This sharp decline follows news of a delay in the inaugural launch of its reusable, medium-lift Neutron rocket to 2027, wiping out recent gains and pulling the stock further away from its 52-week high of $151.00.

🚀 Key Drivers

  • Neutron Delay Shock: The company announced that the maiden launch of its Neutron rocket has been pushed back to 2027, triggering a massive sell-off and breaking investor confidence in near-term catalysts.
  • Earnings Anticipation: With third-quarter earnings approaching, the market is pricing in heightened uncertainty, especially given the negative EPS of -0.28 and a TTM P/E of -162.41.
  • Institutional Sentiment: Despite the drop, 20 out of 24 analysts maintain a Buy or Strong Buy rating, though the immediate reaction reflects risk-off sentiment in high-beta space stocks.

🎯 Price Outlook

Short-Term Upside/Downside Probability

Direction Probability Price Range Change
Upside 40% 48.00 – 52.00 +4% ~ +13%
Downside 60% 42.00 – 45.00 -7% ~ -13%

Mid-Term Upside/Downside Probability

Direction Probability Price Range Change
Upside 45% 55.00 – 70.00 +20% ~ +52%
Downside 55% 37.50 – 42.00 -9% ~ -18%

Key Price Levels

Type Price
Short-Term Resistance 48.00 / 52.00
Short-Term Support 45.00 / 42.00
Strong Support Zone 37.50

(The above forecasts are generated by AI, for reference only, and do not constitute any form of investment advice, trading guidance, or profit commitment.)

1. Technical Analysis 📈

Volume: Trading volume reached 36.20 million shares with a volume ratio of 2.25, indicating panic selling and capitulation-like activity as the stock broke below key short-term support.

MACD: The DIF (-3.86) has crossed below DEA (-3.56), with the histogram turning negative at -0.60, confirming bearish momentum and a fresh sell signal on the daily chart.

RSI: The 6-day RSI plummeted to 24.21, entering oversold territory, while the 12-day RSI sits at 30.46, suggesting the stock may see a technical rebound but remains in a weak trend.

KDJ: The K value (29.94) and J value (9.04) both indicate severe oversold conditions, supporting the possibility of a short-term bounce if sentiment stabilizes.

2. Key Price Levels 🎯

Primary Support: $45.00 (recent low and psychological level). A decisive break below this level could accelerate selling toward the 52-week low of $37.57.

Strong Resistance: $52.00 (previous consolidation zone and gap area). Reclaiming this level is necessary for any meaningful recovery.

Immediate Pivot: $46.50 (opening and intraday balance point). A sustained move back above this level would signal short-term stabilization.

3. Valuation Perspective 💰

Rocket Lab currently trades at a Price-to-Sales (TTM) ratio of 37.54 and a Price-to-Book ratio of 8.27, while the TTM P/E is deeply negative at -162.41. Compared with the space industry average, the valuation remains extremely rich and is entirely supported by future Neutron and space systems growth expectations, leaving little room for execution missteps.

4. Analyst Targets 🎯

Among 24 institutions providing ratings, the average target price is $101.16, with a low of $64.00 and a high of $132.00. The breakdown includes 6 Strong Buy, 14 Buy, and 4 Hold ratings, indicating that while the long-term view remains bullish, the near-term Neutron delay has created a significant gap between price targets and current levels.

5. Weekly Outlook 🔮

The stock is expected to remain highly volatile over the next week, with a likely range of $42.00 to $48.00. A break above $48.00 could trigger a short-covering rally toward $52.00, while a failure to hold $45.00 may open the door to $42.00 and eventually the $37.50 support zone.

Key events to watch in the coming 1-2 weeks:

  • Third-quarter earnings report and management commentary on Neutron development timeline and customer pipeline.
  • Any updates from Synspective or other launch contracts that could restore confidence in execution.
  • Broader risk sentiment in high-beta growth and space stocks, as well as any changes in short interest following the sharp decline.

Risk Disclaimer ⚠️

This content is for informational purposes only and does not constitute investment advice. Stock markets involve risk, and investors should exercise caution. Rocket Lab's valuation is highly dependent on successful execution of the Neutron program, and any further delays or technical setbacks could lead to additional significant downside.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment